Short Interest in Enhabit, Inc. (NYSE:EHAB) Declines By 5.4%

Enhabit, Inc. (NYSE:EHAB - Get Free Report) was the recipient of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 1,220,000 shares, a decline of 5.4% from the December 31st total of 1,290,000 shares. Based on an average daily trading volume, of 375,300 shares, the short-interest ratio is presently 3.3 days. Approximately 2.8% of the company's stock are sold short.

Enhabit Price Performance

Shares of Enhabit stock traded up $0.16 on Wednesday, reaching $8.65. 280,884 shares of the stock were exchanged, compared to its average volume of 273,269. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a market cap of $434.72 million, a PE ratio of -3.73 and a beta of 1.83. The firm's 50 day moving average is $8.04 and its 200-day moving average is $8.04. Enhabit has a one year low of $6.85 and a one year high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period last year, the firm posted $0.03 earnings per share. As a group, analysts anticipate that Enhabit will post 0.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on EHAB shares. Jefferies Financial Group raised shares of Enhabit from a "hold" rating to a "buy" rating and increased their price target for the company from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners reissued a "market perform" rating and issued a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $8.75.

Insider Buying and Selling at Enhabit

In other Enhabit news, Director Stuart M. Mcguigan bought 15,000 shares of Enhabit stock in a transaction dated Tuesday, December 10th. The stock was bought at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the purchase, the director now owns 46,810 shares of the company's stock, valued at $412,396.10. The trade was a 47.15 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeffrey Bolton purchased 4,000 shares of the company's stock in a transaction that occurred on Thursday, December 12th. The stock was acquired at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the purchase, the director now owns 98,144 shares in the company, valued at $852,871.36. This trade represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 1.90% of the company's stock.

Hedge Funds Weigh In On Enhabit

Several large investors have recently bought and sold shares of EHAB. FMR LLC lifted its position in shares of Enhabit by 138.4% in the 3rd quarter. FMR LLC now owns 3,388 shares of the company's stock worth $27,000 after purchasing an additional 1,967 shares during the period. Rhumbline Advisers raised its position in Enhabit by 2.8% in the 4th quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock valued at $631,000 after buying an additional 2,211 shares during the last quarter. Stoneridge Investment Partners LLC lifted its position in shares of Enhabit by 22.6% during the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company's stock worth $98,000 after buying an additional 2,308 shares in the last quarter. Quarry LP boosted its stake in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company's stock valued at $33,000 after acquiring an additional 2,621 shares during the last quarter. Finally, Gladius Capital Management LP increased its holdings in Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company's stock worth $49,000 after acquiring an additional 2,747 shares during the last quarter.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.